by Bill Malloy | Feb 5, 2024 | Cancer, Health, Medication, Pharmaceuticals
The world became familiar with Messenger RNA (mRNA) vaccines during the COVID-19 pandemic, as this was the technology used to develop COVID vaccines so quickly. However, this vaccine technology was originally designed to be used against cancer. A recent study...
by Bill Malloy | Feb 5, 2024 | Cancer, Medication, Pharmaceuticals
A recent Phase III clinical trial for a cancer vaccine called DCVax showed that it could provide patients with extra years beyond their initial prognoses. The vaccine is used to treat glioblastoma, one of the most common, aggressive, and deadly forms of brain cancer....
by Bill Malloy | Jan 23, 2024 | Cancer, Medication, Pharmaceuticals
The world became familiar with Messenger RNA (mRNA) vaccines during the COVID-19 pandemic, as this was the technology used to develop COVID vaccines so quickly. However, this vaccine technology was originally designed to be used against cancer. A recent study...
by Bill Malloy | Sep 29, 2023 | Health, Medication, Pharmaceuticals
Researchers at the prestigious Cleveland Clinic have entered the next phase of a novel study of a vaccine designed to prevent triple-negative breast cancer, which is the most lethal and aggressive type of breast cancer. This new study will evaluate the vaccine’s...
by Bill Malloy | Aug 15, 2023 | Cancer, Health, Pharmaceuticals
A recent immunotherapy clinical trial by the Memorial Sloan Kettering Cancer Center (MSK) yielded unprecedented results—remission for every single participant. While it was a small trial with 14 participants, the results are extremely encouraging. According to MSK...
by Bill Malloy | May 23, 2022 | Health, Medication, Pharmaceuticals
In November 2021, a cancer treatment agent called Cytalux was approved by the US Food and Drug Administration (FDA). Between 22,000 and 24,000 women are diagnosed with ovarian cancer each year in the United States. Oncologists are hopeful that this new treatment can...
